Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- GMDA
- Price
- -
- Stock movement up
- +0.00 (2.22%)
- Company name
- Gamida Cell Ltd
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.44M
- Ent value
- 75.95M
- Price/Sales
- 0.91
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -23.06%
- 1 year return
- -98.81%
- 3 year return
- -86.72%
- 5 year return
- -70.65%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
GMDA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.91 |
| Price to Book | - |
| EV to Sales | 28.40 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 132.64M |
| EPS (TTM) | -0.14 |
| FCF per share (TTM) | -0.52 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.67M |
| Gross profit (TTM) | -3.50M |
| Operating income (TTM) | -33.12M |
| Net income (TTM) | -22.09M |
| EPS (TTM) | -0.14 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -130.74% |
| Operating margin (TTM) | -1238.48% |
| Profit margin (TTM) | -826.10% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 24.78M |
| Net receivables | 1.03M |
| Total current assets | 33.36M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 43.00M |
| Total assets | 79.56M |
| Accounts payable | 5.43M |
| Short/Current long term debt | 78.09M |
| Total current liabilities | 94.70M |
| Total liabilities | 98.29M |
| Shareholder's equity | -18.73M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -79.04M |
| Capital expenditures (TTM) | 343.33K |
| Free cash flow (TTM) | -79.38M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -27.77% |
| Return on Invested Capital | -38.41% |
| Cash Return on Invested Capital | -138.04% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| GMDA | S&P500 | |
| Current price drop from All-time high | -99.88% | -2.85% |
| Highest price drop | -99.94% | -56.47% |
| Date of highest drop | 12 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -71.41% | -11.07% |
| Avg time to new high | 198 days | 12 days |
| Max time to new high | 1359 days | 1805 days |
COMPANY DETAILS
Marketcap
2.44M
Marketcap category
Small-cap
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.
Employees
143
Website
Investor relations
-
SEC filings
CEO
Julian Adams
Country
USA
City
Jerusalem
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner